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S100A8 ⁄A9 deficiency in nonhealing venous 
leg ulcers uncovered by multiplexed 
antibody microarray profiling
Trøstrup et al. compared expression patterns of a large 
panel of 48 proteins in serum and wound fluid of nondia-
betic patients with nonhealing chronic venous leg ulcers 
with those from patients with healing acute wounds using 
a specially designed antibody-based microarray. Most of 
the analysed proteins including proinflammatory mol-
ecules, proteinases, extracellular matrix proteins and 
angiogenic factors were not significantly changed in either 
group. Expression of proinflammatory S100A8 and S100A9 
was exclusively reduced in sera and wound fluids from 
nonhealing venous leg ulcers. Further investigations are 
needed to determine the role of S100A8⁄A9 in nonhealing 
venous leg ulcers. Br J Dermatol 2011; 165: 292–301.
Isotretinoin increases skin-surface levels  
of neutrophil gelatinase-associated lipocalin 
in patients treated for severe acne
The protein neutrophil gelatinase-associated lipocalin 
(NGAL) has recently been identified as a mediator of the 
apoptotic effect of isotretinoin on sebocytes. This paper pro-
vides additional data supporting the clinical relevance of 
NGAL as a mediator of the early effects of isotretinoin. This 
is the first study to report that NGAL protein is increased on 
the skin of subjects during isotretinoin treatment and this 
increase in NGAL precedes decreases in both sebum and 
Propionibacterium acnes counts. A temporal relationship is 
suggested, wherein an increase in NGAL triggers apoptosis 
in sebocytes leading to reduced sebum production and P. 
acnes levels. Br J Dermatol 2011; 165: 302–10.
The effect of aqueous cream BP on the skin 
barrier in volunteers with a previous history 
of atopic dermatitis
Danby et al. investigated 13 volunteers with a previous 
history of atopic dermatitis (AD). Topical application of 
aqueous cream BP resulted in significant elevation of base-
line transepidermal water loss and a concomitant decrease 
in stratum corneum integrity. Measurements made after 
no treatment in volunteers with current AD, at unaffected 
sites, suggest that application of aqueous cream BP nega-
tively affects the skin barrier towards the damaged state 
associated with onset of flares of the disease. Aqueous 
cream BP used as a leave-on emollient caused severe 
damage to the skin barrier in volunteers with a previous 
history of AD. Aqueous cream BP should not be used as 
a leave-on emollient in patients with AD. Br J Dermatol 
2011; 165: 329–34.
Mortality of bullous pemphigoid in 
Switzerland: a prospective study
Cortés et al. prospectively collected data on 115 patients 
with bullous pemphigoid (BP) over a 2-year period in 
Switzerland. The mortality rate of patients with BP was 
three times higher than that of the age- and sex-matched 
general population. Besides age, the presence of neuro-
logical diseases at diagnosis was associated with increased 
mortality in multivariate analysis. Br J Dermatol 2011; 165: 
368–74.
A double-blind placebo-controlled 
randomized trial of adalimumab in the 
treatment of hidradenitis suppurativa
Miller et al. report a randomized controlled trial in which 
adalimumab reduced the disease severity of hidradenitis 
suppurativa (HS) significantly after 6 weeks, and border-
line significantly after 12 weeks of treatment as assessed 
by the primary outcome variable: the Sartorius score 
(P = 0.024 and P = 0.074, respectively). None of the 
secondary endpoints reached statistical significance, 
although quality of life as described by the Dermatology 
Life Quality Index improved greatly and reached a near 
significant value of P = 0.06 after 12 weeks of treatment. 
All patients relapsed 3 months after treatment, indicating 
suppressive rather than curative therapy. Br J Dermatol 
2011; 165: 391–98.
